← Evidence map

ArticleAnnals of hematology2022

Identification of CD105 (endoglin) as novel risk marker in CLL.

Sarah M Greiner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35044512